000 | 01935 a2200565 4500 | ||
---|---|---|---|
005 | 20250516032851.0 | ||
264 | 0 | _c20110826 | |
008 | 201108s 0 0 eng d | ||
022 | _a1556-5653 | ||
024 | 7 |
_a10.1016/j.fertnstert.2011.03.031 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBerent-Spillson, Alison | |
245 | 0 | 0 |
_aInsulin resistance influences central opioid activity in polycystic ovary syndrome. _h[electronic resource] |
260 |
_bFertility and sterility _cJun 2011 |
||
300 |
_a2494-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 | _aCarbon Radioisotopes |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFentanyl _xanalogs & derivatives |
650 | 0 | 4 | _aGlucose Tolerance Test |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
650 | 0 | 4 | _aInsulin Resistance |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 |
_aMetformin _xtherapeutic use |
650 | 0 | 4 | _aMichigan |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 |
_aPolycystic Ovary Syndrome _xdrug therapy |
650 | 0 | 4 | _aPositron-Emission Tomography |
650 | 0 | 4 |
_aReceptors, Opioid, mu _xdrug effects |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
650 | 0 | 4 |
_abeta-Endorphin _xmetabolism |
700 | 1 | _aLove, Tiffany | |
700 | 1 | _aPop-Busui, Rodica | |
700 | 1 | _aSowers, MaryFran | |
700 | 1 | _aPersad, Carol C | |
700 | 1 | _aPennington, Kathryn P | |
700 | 1 | _aEyvazaddeh, Aimee D | |
700 | 1 | _aPadmanabhan, Vasantha | |
700 | 1 | _aZubieta, Jon-Kar | |
700 | 1 | _aSmith, Yolanda R | |
773 | 0 |
_tFertility and sterility _gvol. 95 _gno. 8 _gp. 2494-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.fertnstert.2011.03.031 _zAvailable from publisher's website |
999 |
_c20753287 _d20753287 |